Compared with the previous meta-analysis, our results found that suPAR exhibited higher specificity than CRP and PCT, suggesting that it can better identify non-sepsis neonates and is more distinguishable than other biomarkers in newborns with different inflammatory diseases. Here, CRP is linked to Sepsis.